Search

Your search keyword '"Hydroxylamines adverse effects"' showing total 38 results

Search Constraints

Start Over You searched for: Descriptor "Hydroxylamines adverse effects" Remove constraint Descriptor: "Hydroxylamines adverse effects"
38 results on '"Hydroxylamines adverse effects"'

Search Results

1. Patient-Reported Adverse Events Among Elderly Patients Receiving Novel Oral COVID-19 Antivirals: A Nationwide Sampled Survey in Korea.

2. Effectiveness and safety of molnupiravir in the intended-use population: an observational cohort study.

3. Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

4. Molnupiravir versus favipiravir in at-risk outpatients with COVID-19: A randomized controlled trial in Thailand.

5. Could a popular antiviral supercharge the pandemic?

7. Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.

8. Lethal mutagenesis as an antiviral strategy.

9. An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19.

10. Molnupiravir for treatment of COVID-19.

11. Human genetic risk of treatment with antiviral nucleoside analog drugs that induce lethal mutagenesis: The special case of molnupiravir.

12. Audio Interview: A Potential New Agent to Treat Covid-19.

13. Buyer beware: molnupiravir may damage DNA.

14. Efficacy and safety of arimoclomol in Niemann-Pick disease type C: Results from a double-blind, randomised, placebo-controlled, multinational phase 2/3 trial of a novel treatment.

15. Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors.

16. Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS.

17. Scriptaid enhances skeletal muscle insulin action and cardiac function in obese mice.

18. A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumors.

19. The in vitro platelet toxicity assay (iPTA): a novel approach for assessment of drug hypersensitivity syndrome.

20. Arimoclomol, a coinducer of heat shock proteins for the potential treatment of amyotrophic lateral sclerosis.

21. Arimoclomol: a potential therapy under development for ALS.

22. Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis.

23. Aerobic 2- and 4-nitroreduction of CB 1954 by human liver.

25. Managing drug reactions to sulfonamides and other drugs in HIV infection: desensitization rather than rechallenge?

27. Humoral and haemodynamic effects of idrapril calcium, the prototype of a new class of ACE-inhibitors, in essential hypertensive patients.

28. Allergic contact dermatitis in a photographer.

31. Acquired methemoglobinemia and hemolytic anemia after usual doses of phenazopyridine.

32. Hydroxylamines and hemolytic anemia.

33. Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites.

34. Further tests for carcinogenesis using newborn mice: 2-naphthylamine, 2-naphthylhydroxylamine, 2-acetylaminofluorene and ethyl methane sulphonate.

36. [Allergic eczema due to hydroxylamine salts].

Catalog

Books, media, physical & digital resources